Skip to main content
Livermore
Livermore
ZHEN

Marshall Wace, LLP

SEC CIK
0001318757
Latest filing
Aug 13, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
2,990,512
Value
$752.5M
% of portfolio
0.6%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Marshall Wace, LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,990,512$752.5M0.6%+2,989,451+281,757.9%AddedHolders
Q1 20261,061$230.8K<0.1%−648,939−99.8%ReducedHolders
Q4 2025650,000$148.5M0.1%−627,167−49.1%ReducedHolders
Q3 20251,277,167$295.7M0.3%−102,168−7.4%ReducedHolders
Q2 20251,379,335$256.0M0.3%+1,137,548+470.5%AddedHolders
Q1 2025241,787$50.7M0.1%−1,335,108−84.7%ReducedHolders
Q4 20241,576,895$280.2M0.4%+247,726+18.6%AddedHolders
Q3 20241,329,169$262.5M0.3%+443,254+50.0%AddedHolders
Q2 2024885,915$152.0M0.2%−791,353−47.2%ReducedHolders
Q1 20241,677,268$305.4M0.5%−1,495,772−47.1%ReducedHolders
Q4 20233,173,040$491.7M0.9%−733,450−18.8%ReducedHolders
Q3 20233,906,490$582.3M1.3%+3,004,224+333.0%AddedHolders
Q2 2023902,266$121.6M0.3%+121,471+15.6%AddedHolders
Q1 2023780,795$124.4M0.3%+763,796+4,493.2%AddedHolders
Q4 202216,999$2.75M<0.1%−29,179−63.2%ReducedHolders
Q3 202246,178$6.20M<0.1%−375,414−89.0%ReducedHolders
Q2 2022421,592$64.6M0.1%−778,337−64.9%ReducedHolders
Q1 20221,199,929$194.5M0.4%+886,248+282.5%AddedHolders
Q4 2021313,681$42.5M0.1%+284,278+966.8%AddedHolders
Q3 202129,403$3.17M<0.1%+24,568+508.1%AddedHolders
Q2 20214,835$545.0K<0.1%−171,309−97.3%ReducedHolders
Q1 2021176,144$19.1M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.